CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831381173
- Phone
- (206) 701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −2,825,989 | 8,615,337 | ||
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −4,926,378 | 8,057,470 | ||
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −345,069 | 1,035,208 | ||
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −1,181,745 | 0 | ||
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −2,431,281 | 7,293,841 | ||
| 2023-09-13 | Flagship Pioneering Inc. 10% owner | Other disposition | −70,813 | 0 | ||
| 2023-07-05 | Wilderotter Mary Agnes Director | Grant or award | +1,245 | 3,559 | ||
| 2023-07-05 | Bishop Hans Edgar Director | Grant or award | +4,152 | 5,765,040 | ||
| 2023-06-08 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | REICIN ALISE Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Seitz Michelle Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Wilderotter Mary Agnes Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Cole Douglas G. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Yang Patrick Y Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-08 | Bishop Hans Edgar Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-06-07 | Flagship Ventures Fund V General Partner LLC 10% owner | Sale | −177,240 | $6.24 | $1.1M | 10,743,293 |
| 2023-06-07 | Flagship Ventures Fund V General Partner LLC 10% owner | Sale | −22,760 | $6.24 | $142K | 1,380,277 |
| 2023-06-06 | Flagship Ventures Fund V General Partner LLC 10% owner | Sale | −181,461 | $6.31 | $1.1M | 10,920,533 |
| 2023-06-06 | Flagship Ventures Fund V General Partner LLC 10% owner | Sale | −22,297 | $6.31 | $141K | 1,403,037 |
Page 8 of 9 · 172 trades